Federal Reserve officials last week scrapped a pledge to be 'patient'' when deciding whether to cut U.S. interest rates to ward off an economic downturn. The move was seen as inching the Fed closer to a possible reduction in July. But Robert Kaplan, president of the central bank's Dallas branch, argues in a new essay that 'additional time' is needed to evaluate whether to make any changes in monetary policy.
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
Synchrony, the bank spun off from General Electric in 2014, has posted impressive asset growth and profitability in recent years. But some investors are leery of the stock because of the potential for steep losses if the U.S. economy takes a turn for the worse.
The Federal Reserve's 'stress tests' of big banks requires them to maintain sufficient capital, even after a nightmare economic scenario in which stock prices fall by 65% and unemployment surges to 10%.
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
James Bullard, president of the Federal Reserve Bank of St. Louis, was the only member of the Federal Reserve's monetary-policy committee to vote this week for a cut in the official U.S. interest rate. The panel majority, led by Chair Jerome Powell, voted to keep the rate at 2.25% to 2.5% but warned of risks to the U.S. economy.
Oracle tells investors it can regain the crown it once held among enterprises and end-users, but some aren't so sure.
Is the bad news for Oracle all over?
The healthcare app creator reportedly shelves a Hong Kong listing in favor of "China's Nasdaq" due to data privacy and transparency concerns.